Di Yu

Title: Di Yu - Innovator in IL-21 Agonist Antibodies

Introduction

Di Yu is a prominent inventor based in Glen Waverley, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of IL-21 agonist antibodies. With a total of 3 patents to his name, his work focuses on innovative methods for treating various medical conditions.

Latest Patents

Di Yu's latest patents include groundbreaking inventions related to IL-21. One of his notable patents is titled "IL-21 agonist antibodies and methods of treatment using same." This invention pertains to IL-21, antibodies, and related fragments that bind to IL-21. It also covers the production of these antibodies and their use for detection and therapy of conditions such as inflammation, infection, and oncology. Another significant patent is "Methods of treating cancer using an IL-21 agonist." This disclosure provides proteins that comprise antigen binding sites of antibodies that bind to interleukin-21 (IL-21) and outlines their therapeutic applications.

Career Highlights

Di Yu is affiliated with the Beijing University of Technology, where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to the understanding and treatment of various diseases.

Collaborations

Di Yu has collaborated with notable colleagues, including Charles Reay Mackay and Remy Michel Robert. These partnerships have further enhanced his research efforts and expanded the impact of his inventions.

Conclusion

Di Yu is a distinguished inventor whose work in IL-21 agonist antibodies has the potential to revolutionize treatment methods for critical health conditions. His contributions to biotechnology reflect a commitment to innovation and improving patient outcomes.